Thursday, October 23, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Neutral Rating on Black Stone Minerals with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_ stocks to buy
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Piper Sandler analyst Mark Lear reaffirms his Neutral rating on Black Stone Minerals (NYSE: BSM) while increasing the price target from $16 to $17. Lear’s updated outlook on the company’s performance is reflected in this adjustment. It is worth mentioning that the average price target for Black Stone Minerals stands at $19.00, with projections ranging from $17.00 to $21.00. There have also been cases where the price target was revised down to $15, showcasing the diverse opinions on the company’s valuation and future potential.

BSM Stock Shows Positive Momentum with 0.32% Rise on March 7, 2024: Investors Remain Cautiously Optimistic

On March 7, 2024, BSM stock showed some positive momentum as it experienced a slight increase in its price. BSM shares closed at $15.44, marking a $0.05 increase since the market last closed, representing a 0.32% rise in the stock price.

In pre-market trading, BSM stock rose an additional $0.04, indicating that investors may have a positive outlook on the company’s performance and potential for growth.

Investors should conduct thorough research and analysis before making any investment decisions, as market conditions can change rapidly. It is essential to stay informed and updated on the latest developments that may impact stock performances.

BSM stock showed promising signs on March 7, 2024, with a steady increase in its price. Investors will be closely monitoring the stock’s performance in the coming days to see if this positive momentum continues.

BSM Stock Performance Analysis: Revenue Decline but Net Income Increases

On March 7, 2024, BSM stock showed mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $501.10 million, which decreased by 36.11% compared to the previous year. However, the total revenue remained flat since the last quarter at $136.38 million.

In terms of net income, BSM reported a net income of $422.55 million for the past year, which represented an 11.32% decrease compared to the previous year. On the other hand, the net income for the last quarter was $147.65 million, showing a significant increase of 137.88% since the previous quarter.

Earnings per share (EPS) for BSM stock was $1.88 for the past year, reflecting a 7.5% decrease compared to the previous year. The EPS remained flat since the last quarter at $0.65.

Overall, BSM stock showed a decline in total revenue and net income compared to the previous year. However, the company managed to increase its net income significantly since the last quarter. The EPS remained stable since the last quarter, indicating a potential stabilization in the company’s financial performance.

Tags: BSM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Analyst Reiterates Overweight Rating and Increases Price Target for Chord Energy NASDAQ CHRD

Analyst Reaffirms Buy Rating and Price Target for Mayville Engineering

Pharmaceutical Markets and money

Novo Nordisks Amycretin A GameChanger in Weight Loss Treatment

Recommended

TMUS stock news

JMP Securities Reaffirms Market Outperform Rating for Ocular Therapeutix

2 years ago
Biotechnology Markets and money

Emergent BioSolutions Safeguarding Public Health and National Security

2 years ago
MSA Safety Stock

MSA Safety: A Stock Caught Between Strong Fundamentals and Lofty Valuations

2 months ago
Biopharmaceutical Markets and money (1)

Windtree Therapeutics Engages Ladenburg as Strategic Advisor to Enhance Position in Pharmaceutical Industry

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Standard Lithium Secures Major Funding Injection Amid Market Optimism

Deutsche Bank Shares Face Critical Test Amid Diverging Views

Bitcoin Approaches Critical Juncture Amid Market Volatility and Regulatory Shifts

Legal Battle Sparks Sell-Off in Almonty Shares

Volatus Aerospace Leadership Engages Investors at New York Summit

Voestalpine Joins Industry Coalition in Critical EU Policy Showdown

Trending

Robinhood Stock
Analysis

ARK Invest Makes Major Bet on Robinhood Shares

by Felix Baarz
October 23, 2025
0

Cathie Wood has reemerged with a significant investment move, directing substantial capital toward trading platform Robinhood through...

Marvell Technology Stock

Marvell’s AI-Driven Surge Meets Market Skepticism

October 23, 2025
Banco Santander Brasil Stock

Santander Brasil’s Dual Dividend Payout Presents Investor Opportunity

October 23, 2025
Standard Lithium Stock

Standard Lithium Secures Major Funding Injection Amid Market Optimism

October 22, 2025
Deutsche Bank Stock

Deutsche Bank Shares Face Critical Test Amid Diverging Views

October 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ARK Invest Makes Major Bet on Robinhood Shares
  • Marvell’s AI-Driven Surge Meets Market Skepticism
  • Santander Brasil’s Dual Dividend Payout Presents Investor Opportunity

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com